Evidence map›Paper›PMID 35371464›Full record

ArticleClinical kidney journal2022

Immunogenicity, reactogenicity and breakthrough infections after two doses of the inactivated CoronaVac vaccine among patients on dialysis: phase 4 study.

José Medina-Pestana, Cinthia Montenegro Teixeira, Laila Almeida Viana, Silvia Regina Manfredi, Monica Rika Nakamura, Elizabeth França Lucena, Adriano Luiz Amiratti, Helio Tedesco-Silva, Dimas Tadeu Covas, Marina Pontello Cristelli

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical kidney journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Clinical manifestations of COVID-19 infection in dialysis patients and protective effect of COVID-19 vaccine.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

José Medina-PestanaNephrology Division, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil.
Cinthia Montenegro TeixeiraNephrology Division, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil.
Laila Almeida VianaNephrology Division, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil.
Silvia Regina ManfrediNephrology Division, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil.
Monica Rika NakamuraNephrology Division, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil.
Elizabeth França LucenaNephrology Division, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil.
Adriano Luiz AmirattiNephrology Division, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil.
Helio Tedesco-SilvaNephrology Division, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil.
Dimas Tadeu CovasInstituto Butantan, São Paulo, Brazil.
Marina Pontello CristelliNephrology Division, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-2813-0400

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35371464
PMCPMC8967539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.